Amalthea is a complete, personalized, modular platform,
which provides diagnosis, evaluation of the gut flora, and
treatment of IBDs. A non-invasive encapsulated detection
module, consisting of a genetically engineered bacteria-based
system and an electronic system, will identify metabolite
deficiencies directly correlated to IBDs, that may lead to
malnutrition. Exploiting a bio-electronic interface to
enable real-time monitoring on the patient’s smartphone.
Based on this personalized data, a biosynthetic module
will respond with selective production of the missing
metabolites, thus eliminating that nutritional deficit and
relieving the patient of the symptoms. Our product is
designed according to healthcare experts and international
standards, to ensure bio-safety.